Recent Finacing
Recent Raise
Shanben Biological develops high‑specificity antibody reagents using its ShGE lentivirus‑mediated shRNA gene‑silencing platform to produce validated antibodies, lentiviral libraries, stable cell lines, cell lysates, reagents and diagnostic kits.
Focus Areas
Recent Investors
Funding round
Investor